News provided by Ro Apr 29, 2025, 10:00 ET The NBA legend is spotlighting convenient access to weight loss treatment with Ro NEW YORK, April 29, 2025 /PRNewswire/ -- Ro , the leading direct-to-patient telehealth company, today announced that NBA Hall of Famer and five-time Sports Emmy Award winning broadcaster Charles Barkley is joining on as a GLP-1 celebrity ambassador
Before beginning treatment, a comprehensive medical evaluation is conducted to evaluate the patients general health, review their medical history, and identify any possible contraindications
Is Retatrutide an injection
Recently, top-line results were released of a study in 168 older individual with overweight and obesity who received semaglutide and either 3 mg or 6 mg enobosarm or placebo daily for 16 weeks ( The average weight loss (kg) was 4.7 4.24 for placebo and 4.4 3.9 for pooled enobosarm doses
Can oral options prevent future shortages
"Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes (SUSTAIN 5)"